About Sirnaomics
Sirnaomics is a company based in Gaithersburg (United States) founded in 2007. Sirnaomics has raised $267 million across 17 funding rounds from investors including Maryland.gov, HHS and Bloomage Biotechnology. The company has 69 employees as of December 31, 2024. Sirnaomics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
- Headquarter Gaithersburg, United States
- Employees 69 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sirnaomics Ltd.
-
Annual Revenue
$1.79 M (USD)0as on Dec 31, 2024
-
Net Profit
-$51.62 M (USD)34.92as on Dec 31, 2024
-
EBITDA
-$31.35 M (USD)56.43as on Dec 31, 2024
-
Total Equity Funding
$267 M (USD)
in 17 rounds
-
Latest Funding Round
$17.69 M (USD), Post-IPO
Sep 07, 2025
-
Investors
Maryland.gov
& 14 more
-
Employee Count
69
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sirnaomics
Sirnaomics is a publicly listed company on the HKEX with ticker symbol 2257 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Sirnaomics
Unlock access to complete
Funding Insights of Sirnaomics
Sirnaomics has successfully raised a total of $267M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.69 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sirnaomics
Sirnaomics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Maryland.gov, HHS and Bloomage Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
A venture capital firm focused on life sciences investments.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in blockchain industry
|
Locked | Locked | Locked |
Investor details for Sirnaomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sirnaomics
Investment portfolio details for Sirnaomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sirnaomics
Detailed financials for Sirnaomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sirnaomics Comparisons
Peer comparison for Sirnaomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sirnaomics
Sirnaomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
Detailed competitors of Sirnaomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sirnaomics
Complete news archive for Sirnaomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirnaomics
Sirnaomics was founded in 2007.
Sirnaomics is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Sirnaomics is a funded company, having raised a total of $267M across 17 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Sirnaomics is 69.
Annual revenue of Sirnaomics is $1.79M as on Dec 31, 2024.
Sirnaomics was founded in 2007 and is located in Gaithersburg, United States. RNA-based therapeutics are developed for cancer and fibrosis treatment within the biotechnology sector. Proprietary delivery technologies, including a polypeptide nanoparticle RNAi platform and the GalNAc RNAi platform known as GalAhead, are employed to advance a drug candidate pipeline. This pipeline targets cardiovascular disease, cancers, skin conditions, fibrosis-related diseases, antiviral applications, cardiometabolic conditions, and medical aesthetics.
Sirnaomics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Yes, Sirnaomics is publicly traded on HKEX under the ticker symbol 2257.
Sirnaomics has 15 investors. Key investors include Maryland.gov, HHS, Bloomage Biotechnology, Yuexiu Group, and Walvax.
The ticker symbol of Sirnaomics is 2257 on HKEX.